Henning Mann

HM.BioConsulting Spotlight Series ISSUE 10-1 · MAY 2026 A Strategic Intelligence Report by Henning Mann, HM.BioConsulting, Emma Aitken, Australian Trade & Investment Commission, Michael Phelan, InnovApproach Consulting Prepared by Henning Mann, PhD | Founder & Principal, HM.BioConsulting May 2026 Get the Full Article PDF EXECUTIVE SUMMARY Australia has quietly become a powerful launchpad for early-phase clinical development, and a rising hub for New Approach Methodologies (NAMs),...

A Conversation between Rebecca Clyde, PhD, Botco.ai, and Henning Mann, PhD, HM.BioConsulting Authors: Rebecca Clyde, Desiree Goubert, Henning Mann Clinical trial matching is entering a new phase where advanced AI is embedded directly into clinical workflows, enabling a meaningful shift in speed and accessibility. In a recent discussion with Rebecca Clyde, Co-founder and CEO of Botco.ai, we discussed how this approach connects patients, physicians, and trial sponsors while reducing the time...

A Reflection by Désirée Goubert, PhD, & Henning Mann, PhD; HM.BioConsulting Download PDF here: There is something quietly profound about the idea that human tissue models have now travelled beyond low Earth orbit, circled the moon, and returned. As a first, not as a vision or grant proposal, let alone a symbolic gesture, but indeed as working and applied biological systems designed to answer a very practical question: how does the human body respond to extreme environments? Organ-on-a-chip...